
GSK
Healthcare · Drug Manufacturers - General · $101.13B market cap
$50.45-0.19 (-0.4%)Nov 13, 4:03 PM EST
Latest report
Before the open
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Dec 31, 2026
EPS trend, 90 days to now · -11.0% over 90 days · 30-day revisions 0 up, 1 down
Beat estimates in 4 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Oct 28, 2026 | Before the open | 1.40 | 1.47 | +5.0% |
| Jul 28, 2026 | Before the open | 1.27 | 1.36 | +7.1% |
| Apr 29, 2026 | Before the open | 1.16 | 1.26 | +8.6% |
| Feb 4, 2026 | Before the open | 0.62 | 0.70 | +12.9% |
| Oct 29, 2025 | Before the open | 1.26 | 1.46 | +15.9% |
| Jul 30, 2025 | Before the open | 1.11 | 1.24 | +11.7% |
| Apr 30, 2025 | Before the open | 1.04 | 1.20 | +15.4% |
| Feb 5, 2025 | Before the open | 0.49 | 0.58 | +18.4% |
| Oct 30, 2024 | Before the open | 1.16 | 1.29 | +11.2% |
| Jul 31, 2024 | Before the open | 0.98 | 1.11 | +13.3% |
| May 1, 2024 | Before the open | 0.94 | 1.08 | +14.9% |
| Jan 31, 2024 | Before the open | 0.77 | 0.73 | -5.2% |
| Nov 1, 2023 | Before the open | 1.14 | 1.22 | +7.0% |
GSK plc, together with its subsidiaries, engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally. It operates through Commercial Operations and Total R&D segments. The company offers specialty medicines that include oncology, respiratory/immunology, inflammation, and…
| Jul 26, 2023 | Before the open | 0.87 | 1.00 | +14.9% |
| Apr 26, 2023 | Before the open | 0.82 | 0.92 | +12.2% |
| Feb 1, 2023 | Before the open | 0.55 | 0.64 | +16.4% |
| Nov 2, 2022 | Before the open | 0.89 | 1.07 | +20.2% |
| Jul 27, 2022 | Before the open | 0.73 | 0.87 | +19.2% |
| Apr 27, 2022 | Before the open | 0.96 | 1.03 | +7.3% |
| Feb 9, 2022 | Before the open | 0.81 | 0.87 | +7.4% |
| Oct 27, 2021 | Before the open | 1.02 | 1.26 | +23.5% |
| Jul 28, 2021 | Before the open | 0.41 | 0.98 | +139.0% |
| Apr 28, 2021 | Before the open | 0.60 | 0.80 | +33.3% |
| Feb 3, 2021 | Before the open | 0.60 | 0.80 | +33.3% |
| Oct 28, 2020 | Before the open | 1.07 | 1.16 | +8.4% |
| Jul 29, 2020 | Before the open | 0.71 | 0.62 | -12.7% |
| Apr 29, 2020 | Before the open | 0.78 | 1.16 | +48.7% |
| Feb 5, 2020 | Before the open | 0.76 | 0.81 | +6.6% |
| Oct 30, 2019 | Before the open | 1.00 | 1.24 | +24.0% |
| Jul 24, 2019 | Before the open | 0.78 | 0.95 | +21.8% |
| May 1, 2019 | Before the open | 0.80 | 0.98 | +22.5% |
| Feb 6, 2019 | Before the open | 0.88 | 1.01 | +14.8% |
| Oct 31, 2018 | Before the open | 1.07 | 1.13 | +5.6% |
| Jul 25, 2018 | Before the open | 0.97 | 0.92 | -5.2% |
| Apr 25, 2018 | Before the open | 0.86 | 0.86 | 0.0% |
| Feb 7, 2018 | Before the open | 0.84 | 0.94 | +11.9% |